Logo image of JGH

NUVEEN GLOBAL HIGH INCOME (JGH) Stock Price, Quote, News and Overview

NYSE:JGH - New York Stock Exchange, Inc. - US67075G1031 - Currency: USD

12.67  +0.12 (+0.96%)

Fundamental Rating

2

Taking everything into account, JGH scores 2 out of 10 in our fundamental rating. JGH was compared to 0 industry peers in the Unkown industry. JGH may be in some trouble as it scores bad on both profitability and health. JGH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JGH had positive earnings in the past year.
In the past year JGH had a positive cash flow from operations.
In multiple years JGH reported negative net income over the last 5 years.
JGH had a positive operating cash flow in each of the past 5 years.
JGH Yearly Net Income VS EBIT VS OCF VS FCFJGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

The last Return On Invested Capital (3.65%) for JGH is above the 3 year average (3.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.52%
ROE 10.82%
ROIC 3.65%
ROA(3y)0.14%
ROA(5y)2.63%
ROE(3y)0%
ROE(5y)3.64%
ROIC(3y)3.65%
ROIC(5y)3.64%
JGH Yearly ROA, ROE, ROICJGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

In the last couple of years the Operating Margin of JGH has declined.
JGH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 65.59%
PM (TTM) 108.19%
GM 66.37%
OM growth 3Y-7.29%
OM growth 5Y-3.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.05%
GM growth 5Y-3.07%
JGH Yearly Profit, Operating, Gross MarginsJGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200

3

2. Health

2.1 Basic Checks

JGH has about the same amout of shares outstanding than it did 1 year ago.
JGH has about the same amout of shares outstanding than it did 5 years ago.
JGH has a better debt/assets ratio than last year.
JGH Yearly Shares OutstandingJGH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
JGH Yearly Total Debt VS Total AssetsJGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

JGH has an Altman-Z score of 1.01. This is a bad value and indicates that JGH is not financially healthy and even has some risk of bankruptcy.
JGH has a debt to FCF ratio of 2.52. This is a good value and a sign of high solvency as JGH would need 2.52 years to pay back of all of its debts.
A Debt/Equity ratio of 0.40 indicates that JGH is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.52
Altman-Z 1.01
ROIC/WACCN/A
WACCN/A
JGH Yearly LT Debt VS Equity VS FCFJGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.3 Liquidity

JGH has a Current Ratio of 1.49. This is a normal value and indicates that JGH is financially healthy and should not expect problems in meeting its short term obligations.
JGH has a Quick Ratio of 1.49. This is a normal value and indicates that JGH is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.49
JGH Yearly Current Assets VS Current LiabilitesJGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 173.10% over the past year.
Looking at the last year, JGH shows a small growth in Revenue. The Revenue has grown by 1.53% in the last year.
Measured over the past years, JGH shows a decrease in Revenue. The Revenue has been decreasing by -5.26% on average per year.
EPS 1Y (TTM)173.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.58%
Revenue 1Y (TTM)1.53%
Revenue growth 3Y-2.29%
Revenue growth 5Y-5.26%
Sales Q2Q%5.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JGH Yearly Revenue VS EstimatesJGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.96, the valuation of JGH can be described as very cheap.
JGH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.25.
Industry RankSector Rank
PE 6.96
Fwd PE N/A
JGH Price Earnings VS Forward Price EarningsJGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.22
EV/EBITDA N/A
JGH Per share dataJGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.12%, JGH is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.40, JGH pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.12%

5.2 History

The dividend of JGH decreases each year by -1.68%.
JGH has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-1.68%
Div Incr Years0
Div Non Decr Years0
JGH Yearly Dividends per shareJGH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

95.20% of the earnings are spent on dividend by JGH. This is not a sustainable payout ratio.
DP95.2%
EPS Next 2YN/A
EPS Next 3YN/A
JGH Yearly Income VS Free CF VS DividendJGH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M
JGH Dividend Payout.JGH Dividend Payout, showing the Payout Ratio.JGH Dividend Payout.PayoutRetained Earnings

NUVEEN GLOBAL HIGH INCOME

NYSE:JGH (5/30/2025, 8:09:00 PM)

12.67

+0.12 (+0.96%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners40.72%
Inst Owner Change0.84%
Ins Owners0.07%
Ins Owner Change0%
Market Cap293.69M
Analysts0
Price TargetN/A
Short Float %0.06%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield 9.12%
Yearly Dividend1.24
Dividend Growth(5Y)-1.68%
DP95.2%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-15 2025-05-15 (0.1035)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.96
Fwd PE N/A
P/S 9.98
P/FCF 6.22
P/OCF 6.22
P/B 1
P/tB 1
EV/EBITDA N/A
EPS(TTM)1.82
EY14.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.04
FCFY16.06%
OCF(TTM)2.04
OCFY16.06%
SpS1.27
BVpS12.7
TBVpS12.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 10.82%
ROCE 4.62%
ROIC 3.65%
ROICexc 3.65%
ROICexgc 3.69%
OM 65.59%
PM (TTM) 108.19%
GM 66.37%
FCFM 160.26%
ROA(3y)0.14%
ROA(5y)2.63%
ROE(3y)0%
ROE(5y)3.64%
ROIC(3y)3.65%
ROIC(5y)3.64%
ROICexc(3y)3.65%
ROICexc(5y)3.65%
ROICexgc(3y)3.68%
ROICexgc(5y)3.68%
ROCE(3y)4.62%
ROCE(5y)4.61%
ROICexcg growth 3Y-1.7%
ROICexcg growth 5Y-3.94%
ROICexc growth 3Y-1.72%
ROICexc growth 5Y-4.02%
OM growth 3Y-7.29%
OM growth 5Y-3.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.05%
GM growth 5Y-3.07%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.52
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.53
Cash Conversion N/A
Profit Quality 148.13%
Current Ratio 1.49
Quick Ratio 1.49
Altman-Z 1.01
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.53%
Revenue growth 3Y-2.29%
Revenue growth 5Y-5.26%
Sales Q2Q%5.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.8%
EBIT growth 3Y-9.41%
EBIT growth 5Y-8.31%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.72%
FCF growth 3Y-14.28%
FCF growth 5Y1.87%
OCF growth 1Y6.72%
OCF growth 3Y-14.28%
OCF growth 5Y1.87%